The Trop-2 signalling network in cancer growth

E Guerra1, M Trerotola, A L Aloisi

  • 1Unit of Cancer Pathology, Department of Oncology and Experimental Medicine and CeSI, Foundation University 'G. d'Annunzio', Chieti, Italy.

Oncogene
|May 8, 2012
PubMed

Insights

Trop-2 (trophoblast cell surface antigen 2) plays a critical role in human cancer growth. This study identifies the complex transcription network regulating Trop-2 expression and its downstream signaling pathways involved in tumor development.

Area of Science:

  • Molecular Oncology
  • Gene Regulation
  • Cancer Biology

Background:

  • Trop-2 (trophoblast cell surface antigen 2) is upregulated in human cancers and drives tumor growth.
  • The regulatory mechanisms controlling TROP2 gene expression remain largely unknown.

Purpose of the Study:

  • To elucidate the TROP2 transcription control network.
  • To understand how Trop-2 expression influences downstream signaling pathways crucial for cancer progression.

Main Methods:

  • Bioinformatic analysis of gene regulatory networks.
  • In silico identification of transcription factor binding sites.
  • Correlation analysis of network component co-expression with Trop-2 in human tumors.

Main Results:

  • Identified a complex web of transcription factors regulating TROP2, with HNF4A as a key hub.
  • Demonstrated that Trop-2 upregulation activates downstream pathways including CREB1, Jun, NF-κB, and STATs via cyclin D1 and ERK/MEK.
  • Showed that growth-stimulatory signaling requires an intact Trop-2 cytoplasmic tail.

Conclusions:

  • The TROP2 transcription network is intricately linked to cancer growth.
  • Co-expression of network components with Trop-2 in tumors supports its role in tumorigenesis.
  • Targeting this network may offer novel therapeutic strategies for cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...